Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review
Thyroid® · 2023-04 · 33 (4) · 420-427
DOI: 10.1089/thy.2022.0692 ↗Kurz gefasst
Scoping Review in der Zeitschrift Thyroid®, online erschienen am 10.04.2023. Verfasst von Roger Chou und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University…. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
For cytologically benign thyroid nodules with very low to intermediate suspicion ultrasound patterns, optimal ultrasound follow-up intervals and outcomes of discontinuing follow-up are unclear.
Methods
Ovid MEDLINE, Embase, and Cochrane Central were searched through August 2022 for studies comparing different ultrasound follow-up intervals and discontinuation versus continuation of ultrasound follow-up. The population was patients with cytologically benign thyroid nodules and very low to intermediate suspicion ultrasound patterns, and the primary outcome was missed thyroid cancers. Utilizing a scoping approach, we also included studies that were not restricted to very low to intermediate suspicion ultrasound patterns or evaluated additional outcomes such as thyroid cancer-related mortality rate, nodule growth, and subsequent procedures. Quality assessment was performed, and evidence was synthesized qualitatively.
Results
One retrospective cohort study ( n = 1254; 1819 nodules) compared different first follow-up ultrasound intervals for cytologically benign thyroid nodules. There was no difference between >4- versus 1- to 2-year intervals to first follow-up ultrasound in the likelihood of malignancy (0.4% [1/223] vs. 0.3% [2/715]), and no cancer-related deaths occurred. Follow-up ultrasound at >4 years was associated with increased likelihood of ≥50% nodule growth (35.0% [78/223] vs. 15.1% [108/715]), repeat fine needle aspiration (19.3% [43/223] vs. 5.6% [40/715]), and thyroidectomy (4.0% [9/223] vs. 0.8% [6/715]). The study did not describe ultrasound patterns or control for confounders, and analyses were based on interval to first follow-up ultrasound only. Other methodological limitations were not controlling for variability in follow-up duration and unclear attrition. The certainty of evidence was very low. No study compared discontinuation of ultrasound follow-up versus continuation.
Conclusions
This scoping review found that evidence comparing different ultrasound follow-up intervals in patients with benign thyroid nodules is limited to one observational study, but suggests that the subsequent development of thyroid malignancies is very uncommon regardless of follow-up interval. Longer follow-up may be associated with more repeat biopsies and thyroidectomies, which could be related to more interval nodule growth that meets thresholds for further evaluation. Research is needed to clarify optimal ultrasound follow-up intervals for low to intermediate suspicion cytologically benign thyroid nodules and outcomes of discontinuing ultrasound follow-up for very low suspicion nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA.
- Division of Endocrinology, Diabetes, and Metabolism, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University, Nashville, Tennessee, USA.
- Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Chou, R., Dana, T., Mayson, S. E., Cibas, E. S., Durante, C., Solórzano, C. C., Mandel, S. J., & Orloff, L. A. (2023). Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review. Thyroid®, 33(4), 420-427. https://doi.org/10.1089/thy.2022.0692
Vancouver
Chou R, Dana T, Mayson SE, Cibas ES, Durante C, Solórzano CC, et al. Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review. Thyroid®. 2023;33(4):420-427. doi:10.1089/thy.2022.0692
BibTeX
@article{Chou2023,
author = {Chou, Roger and Dana, Tracy and Mayson, Sarah E and Cibas, Edmund S and Durante, Cosimo and Solórzano, Carmen C and Mandel, Susan J and Orloff, Lisa A},
title = {Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review},
journal = {Thyroid®},
year = {2023},
volume = {33},
number = {4},
pages = {420--427},
doi = {10.1089/thy.2022.0692}
}
EUVIMED